Talis Biomedical Corp (TLIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 9,486 | 820 | 399 | 0 |
| Gross Profit | 9,486 | 820 | 399 | N/A |
| Operating Expenses | 39,069 | 10,844 | 7,794 | 0 |
| Operating Income | -29,583 | -10,024 | -7,395 | N/A |
| Other Income | 69 | -22 | 21 | 0 |
| Pre-tax Income | -29,514 | -10,046 | -7,374 | 0 |
| Net Income Continuous | -29,514 | -10,046 | -7,374 | N/A |
| Net Income | $-29,514 | $-10,046 | $-7,374 | $N/A |
| EPS Basic Total Ops | -208.40 | -71.21 | -52.32 | N/A |
| EPS Basic Continuous Ops | -208.43 | -71.16 | -52.25 | N/A |
| EPS Diluted Total Ops | -208.40 | -71.21 | -52.32 | N/A |
| EPS Diluted Continuous Ops | -208.43 | -71.16 | -52.25 | N/A |
| EBITDA(a) | $-29,397 | $-9,831 | $-7,210 | $N/A |